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Introduction
The two major subsets of peripheral T cells express either 
the CD4 or CD8 coreceptor molecules. CD4-expressing 
cells constitute MHC class II-restricted helper T cells, 
while CD8-expressing T cells represent MHC class 
I-restricted cytotoxic T cells. CD4+ and CD8+ T cells 
develop in the thymus from so-called double-positive (DP) 
thymocytes that express both CD4 and CD8. Since the 
helper T cell phenotype is linked with CD4 expression and 
since cytotoxic T cells express CD8, it was hypothesized 
that the regulation of coreceptor gene expression is closely 
interconnected with CD4/CD8 cell-fate choice of DP thy-
mocytes. Therefore, the characterization of the molecular 
details of how the expression of CD4 and CD8 is regulated 
was a promising approach to also obtain insight into the 
regulation of CD4/CD8 cell-fate choice. Indeed, the identi-
fication of the cis-regulatory networks driving Cd4 and Cd8 
and the isolation of transcription factors regulating their 
expression provided not only fundamental insight into tran-
scriptional control mechanisms during T cell development 
but also led to the identification of important members of 
the transcription factor network regulating cell-fate choice 
of DP thymocytes.
In this review, we first provide a brief overview about 
T cell development and CD4/CD8 cell-fate choice of DP 
thymocytes. we then describe the major cis-regulatory ele-
ments known to direct Cd4, Cd8a, and Cd8b1 gene expres-
sion during T cell development and in peripheral T cells. 
Moreover, we present the transcription factors implicated 
Abstract The differentiation and function of periph-
eral helper and cytotoxic T cell lineages is coupled with 
the expression of CD4 and CD8 coreceptor molecules, 
respectively. This indicates that the control of coreceptor 
gene expression is closely linked with the regulation of 
CD4/CD8 lineage decision of DP thymocytes. Research 
performed during the last two decades revealed compre-
hensive mechanistic insight into the developmental stage- 
and subset/lineage-specific regulation of Cd4, Cd8a and 
Cd8b1 (Cd8) gene expression. These studies provided 
important insight into transcriptional control mechanisms 
during T cell development and into the regulation of cis-
regulatory networks in general. Moreover, the identifi-
cation of transcription factors involved in the regulation 
of CD4 and CD8 significantly advanced the knowledge 
of the transcription factor network regulating CD4/CD8 
cell-fate choice of DP thymocytes. In this review, we 
provide an overview of the identification and characteri-
zation of CD4/CD8 cis-regulatory elements and present 
recent progress in our understanding of how these cis-
regulatory elements control CD4/CD8 expression during 
T cell development and in peripheral T cells. In addition, 
we describe the transcription factors implicated in the 
regulation of coreceptor gene expression and discuss how 
these factors are integrated into the transcription factor 
network that regulates CD4/CD8 cell-fate choice of DP 
thymocytes.
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in the regulation of coreceptor gene expression and dis-
cuss how these transcription factors are integrated into the 
transcription factor network that regulates CD4/CD8 cell-
fate decision of DP thymocytes. Finally, we discuss recent 
advances in the three-dimensional control of nuclear posi-
tioning and interchromosomal interaction between the Cd4 
and Cd8 loci. For a detailed in-depth description about the 
initial characterization of the various Cd4 and Cd8 cis-reg-
ulatory elements including the promoter regions, we refer 
to a previously published review [1].
T cell development and models of CD4/CD8 lineage 
commitment
The two major subsets of peripheral T cells express either 
the CD4 or the CD8 coreceptor molecules. CD4+ cells 
express a T cell receptor (TCR) specific for MHC class II 
and constitute the helper T cell population, while CD8+ 
T cells (which usually express CD8 molecules formed by 
heterodimers of the CD8α and CD8β chains encoded by 
the Cd8a and Cd8b1 genes, respectively) express a TCR 
specific for MHC class I and represent the cytotoxic T 
cell pool. T cells develop in the thymus and the genera-
tion of CD4+ and CD8+ T cells is probably one of the best 
described developmental systems in mammals. During T 
cell development, the expression of CD4 and CD8 corecep-
tors is dynamically regulated and linked to the generation 
of helper and cytotoxic T cells. Based on the expression 
of CD4 and CD8, four major developmental stages of T 
cells can be distinguished (Fig. 1). So-called double-neg-
ative (DN) thymocytes that neither express CD4 nor CD8 
define the earliest stages of developing thymocytes. At 
the DN stage, which can be further subdivided according 
the expression of CD44 and CD25, it is decided whether 
T cells develop towards the αβTCR or γδTCR T cell line-
age. For cells committed to the αβT cell lineage, only those 
that have generated a functional TCRβ chain as a conse-
quence of productive vDJ recombination of the Tcrb locus 
will proliferate and expand (the “β-selection” checkpoint), 
start to express CD8 and then CD4 and hence progress to 
CD4+CD8+ double-positive stage (DP) thymocytes. Dur-
ing the transition from the DN to the DP stage, cells also 
initiate the recombination of the Tcra chain locus, lead-
ing to the expression of a functional αβTCR complex on 
DP cells. At the DP stage, thymocytes undergo positive/
negative selection events and CD4/CD8 cell-fate choice, 
resulting in the generation of CD4 and CD8 single-positive 
(SP) thymocytes that eventually exit the thymus to consti-
tute the peripheral T cell pool. CD4 and CD8 contribute 
to this selection process by influencing the avidity of the 
TCR-self-peptide/MHC interaction, since CD4 and CD8 
bind to the membrane-proximal invariant domains of the 
MHC class II and class I molecules, respectively [2, 3] and 
thus function as coreceptors. In addition, they influence the 
signaling function of the ligated TCR complex, since CD4 
and CD8α bind to Lck (although with different affinities) 
via their cytoplasmic domains [4, 5]. The importance of the 
CD4 and CD8 coreceptor molecules is also demonstrated 
by the fact that CD4 or CD8-deficient mice have severely 
impaired helper or cytotoxic T cell development, respec-
tively [6–8]. The positive/negative selection processes at 
the DP stage ensure the generation of a functional periph-
eral T cell pool with a diverse and broad specificity against 
foreign antigens presented by MHC molecules while 
potentially autoreactive T cells are deleted. For excellent 
and detailed reviews about several aspects of T cell devel-
opment, we refer the reader to [9–12].
It was long-debated whether the TCR ligation in DP thy-
mocytes by MHC at the onset of positive selection induces 
an instructive or a stochastic-selective signal that regulates 
CD4/CD8 cell-fate choice [13–16]. experimental data 
supporting the “instructive model” of CD4/CD8 cell-fate 
decision suggested that TCR-MHC signals might quantita-
tively and/or qualitatively differ (in strength and duration) 
between MHC class II-signaled and MHC class I-signaled 
Fig. 1  Simplified model of T cell development. Four major develop-
mental stages of thymocytes can be distinguished based on CD4 and 
CD8 coreceptor expression: DN (CD4−CD8−), DP (CD4+CD8+), 
CD4SP (CD4+CD8−), and CD8SP (CD4−CD8+) thymocytes. DN 
cells develop into DP cells, which mature into CD4 and CD8SP thy-
mocytes. At the onset of positive selection, DP thymocytes transcrip-
tionally shut down CD8 expression, independently of whether they 
received MHC class I or class II signals. This results in the appearance 
of intermediate CD4+CD8lo cells. According to the “kinetic signaling 
model”, CD4+CD8lo cells expressing a MHC class II-restricted TCR 
have persisting TCR signaling and develop towards the CD4 helper 
T cell lineage (CD4SP). If CD4+CD8lo cells express a MHC class 
I-restricted TCR, then TCR signaling is interrupted (due to the down-
regulation of CD8). As a consequence, CD4+CD8lo cells become sus-
ceptible to common cytokine receptor γ chain signaling (induced by 
IL-7 and Il-15), which leads to their specification into the CD8 cyto-
toxic T cell (CD8SP) lineage accompanied with to the cessation of 
CD4 expression and the re-expression of CD8 (“coreceptor reversal”) 
(dashed arrow). See text for more details. Adapted from [17]
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DP cells leading to termination of inappropriate coreceptor 
gene expression. However, data supporting the “stochastic-
selective model” suggested that the initial lineage decision 
of DP thymocytes, characterized by the down-regulation 
of either CD4 or CD8, occurs independently of the MHC 
specificity (i.e., randomly) of the TCR expressed on DP 
thymocytes and is followed by a proof-reading mechanism 
that ensures that the T cell lineage matches the MHC-spec-
ificity of the TCR. A comprehensive overview of the vari-
ous models and the experimental data supporting/conflict-
ing them has been recently provided [17]. New insight into 
how CD4/CD8 cell-fate choice is regulated came from the 
observation that the kinetic of CD4 and CD8 expression 
in DP thymocytes is different in response to TCR–MHC 
interactions [18]. It has been shown that MHC-signaled 
DP thymocytes transcriptionally shut off Cd8 but not Cd4 
gene expression, independent of whether DP cells received 
an MHC class I or class II signal [18]. The down-regula-
tion of CD8 leads to the appearance of CD4+CD8lo thy-
mocytes, a key population of lineage uncommitted cells 
with the potential to develop towards either CD4 or CD8 
lineage T cells [19, 20]. According to the “kinetic signal-
ing model” proposed by Singer and colleagues [17, 18], 
CD4+CD8lo cells expressing an MHC class II-restricted 
TCR continue to signal via their TCR, since the down-reg-
ulation of CD8 in MHC class II-signaled DP thymocytes 
does not interfere with the duration/strength of CD4/TCR-
MHC class II engagement, leading to the development of 
CD4 lineage T cells. In contrast, for thymocytes express-
ing a TCR specific for MHC class I, the down-regulation 
of CD8 leads to an interruption of CD8/TCR-MHC class 
I signals. As a consequence of the cessation of TCR sig-
nals, CD4+CD8lo cells become susceptible to common 
cytokine receptor γ chain (γc) signaling induced by IL-7 
as well as IL-15, which is essential for the specification 
of the CD8 lineage fate [21, 22]. CD8 lineage specifica-
tion of CD4+CD8lo cells is accompanied by the termina-
tion of Cd4 gene expression and the re-initiation of Cd8 
gene expression, a process termed “coreceptor reversal” 
(Fig. 1) [18]. Recently, the importance of the kinetic of 
Cd4 and Cd8 gene expression has been elegantly dem-
onstrated by generating knock-in mice in which the Cd4 
gene was inserted into the Cd8a gene locus [23]. In these 
mice, MHC-signaled DP cells transiently down-regulated 
CD4 expression, and as a consequence, TCR-MHC class 
II signaling is interrupted. Indeed, as predicted from the 
kinetic signaling model, this led to the development of 
MHC class II-restricted CD4+ T cells with cytotoxic T cell 
properties. This demonstrates that thymocytes express-
ing CD4 with the kinetic of CD8 develop into cytotoxic T 
cells, thus providing convincing evidence that the kinetic 
of coreceptor gene expression is critical for CD4/CD8 lin-
eage choice.
Cis‑regulatory elements controlling Cd4 gene 
expression
The murine Cd4 locus maps within an 80-kb region on 
mouse chromosome 6 and shares a similar exon/intron 
structure with its human counterpart that is located on 
human chromosome 12. The mapping of DNase I hyper-
sensitivity sites (DHS) around the murine Cd4 locus and 
the subsequent testing of genomic fragments containing 
DHS for enhancer activity in a large number of transgenic 
reporter expression assays has led to the identification of 
several cis-regulatory elements that direct the expres-
sion of CD4 during T cell development [24–27]. These 
Fig. 2  Map of the Cd4 gene locus. The upper panel shows the Cd4 
gene locus and the horizontal arrow indicates the transcriptional 
orientation of the Cd4 gene. Vertical black and open bars/squares 
indicate exons and the 3′ untranslated regions. Vertical arrows indi-
cate DNase I hypersensitivity sites [24–26, 127]. The red rectangles 
indicate the location of Cd4 enhancers e4D (located approx. 24 kb 
upstream of the Cd4 promoter), e4P (13 kb upstream), and e4T (20 kb 
downstream of the 3′ end), while the triangle indicates the location 
of the Cd4 silencer (S4). Only those trans-acting factors are indi-
cated where binding has been confirmed in primary thymocytes and 
T cells by chromatin immunoprecipitation assays (see text for more 
details). Drawing is adapted from reference [71]. The following refer-
ences report binding to the Cd4 gene locus: Runx complexes [73, 75], 
ThPOK [64, 128], Ikaros/Mi-2β [89], AP4 [92], HeB/e2A [93]
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studies revealed the existence of several positive-acting 
cis-elements (i.e., Cd4 enhancers) as well as the presence 
of a negative-acting cis-element, the so-called Cd4 silencer 
(S4), in addition to the Cd4 promoter (P4) (Fig. 2).
Cd4 enhancers display T cell-specific activities
The proximal Cd4 enhancer e4P maps approximately 13 kb 
upstream of the Cd4 promoter and transgenic reporter assays 
and in vitro transfection experiments resulted in the identifi-
cation of the 339 bp e4P core fragment [25]. The generation 
of transgenic minigenes containing e4P, the Cd4 promoter, 
and human CD2 as a reporter gene indicated that e4P directs 
expression in all thymocyte subsets as well as in CD4+ and 
CD8+ T cells and thus that e4P functions as a general T cell-
specific enhancer. These data already indicated the existence 
of a negative-acting cis-element that counterbalances the 
activity of e4P in CD8 lineage T cells (see below).
Two other Cd4 enhancers are less well characterized. 
The so-called distal Cd4 enhancer e4D resides approxi-
mately 24 kb upstream of the Cd4 promoter [28]. However, 
it is not clear whether this enhancer regulates Cd4 expres-
sion or the expression of a neighboring gene (Lag3), which 
is located immediately upstream of e4D. In transgenic 
reporter expression assays, the combination of e4D and 
e4P resulted in the expression of the reporter gene not only 
in T cells but also in B cells and macrophages, suggesting 
that e4D might not regulate Cd4 [26]. Another element, the 
so-called thymic enhancer e4T, located 36 kb downstream 
of the Cd4 gene, was shown to be necessary for efficient 
transgene expression in DP thymocytes [29].
The Cd4 silencer: a genomic fragment that restricts CD4 
expression to helper lineage T cells
The transgenic reporter expression assays indicated that 
the helper-lineage-specific expression of CD4 is depend-
ent on the presence of a region within intron 1 in the Cd4 
locus, which has been mapped to a 434-bp fragment des-
ignated as Cd4 silencer. A similar Cd4 silencer fragment 
has also been identified in the human Cd4 gene locus 
[30]. while the expression of the transgenic reporter gene 
(hCD2 driven by e4P and P4) in the presence of the Cd4 
silencer was restricted to T cells that express CD4 (i.e., DP 
and CD4SP thymocytes and CD4+ T cells), the removal of 
the Cd4 silencer region from the transgenic reporter con-
struct resulted in the expression of the reporter gene also 
in CD8 lineage T cells as well as in DN thymocytes [27]. 
These studies indicated that the Cd4 silencer activity is 
dynamically regulated during T cell development. The Cd4 
silencer is active in DN thymocytes, inactivated during the 
transition to the DP stage, and reactivated specifically in 
thymocytes developing towards the cytotoxic lineage [27].
Gene targeting approaches to study Cd4  cis-regulatory 
elements: evidence for epigenetic regulation of Cd4 gene 
expression
The importance of the Cd4 silencer in the regulation of Cd4 
gene expression was confirmed by gene targeting studies. 
The germline deletion of the Cd4 silencer resulted in the 
derepressed expression of the Cd4 gene both in DN thymo-
cytes and in CD8 lineage T cells [31, 32], demonstrating 
the essential role for the Cd4 silencer is the repression of 
CD4. By using a conditional Cd4 silencer allele, Littman 
and colleagues [32] further showed that CD4 continued to 
be transcriptionally silent upon deletion of the Cd4 silencer 
in mature CD8+ T cells, even if the cells underwent several 
rounds of proliferation. Together, these data indicate that 
the Cd4 silencer is essential for the establishment of silenc-
ing during the commitment phase towards the CD8 lineage, 
but not for the maintenance once Cd4 silencing has been 
established in peripheral CD8+ T cells. Mechanistically, the 
maintenance of Cd4 silencing in the absence of the silencer 
appears to be independent of DNA methylation [32]. How-
ever, ChIP assays revealed that the repressive histone marks 
tri-methylation of histone 3 at lysine 9 (H3K9me3) or 27 
(H3K27me3) are increased in the Cd4 promoter region in 
CD8+ T cells [33], suggesting that these epigenetic histone 
marks might be involved in the stable repression of CD4. 
Further studies are required to determine how these marks 
at the Cd4 promoter are established and whether they are 
indeed involved the regulation of Cd4 silencing in CD8+ 
T cells. Interestingly, it has been shown that MHC class 
II-restricted CD4−CD8+ T cells that develop in ThPOK-
null mice (as described in more detail below) up-regulate 
CD4 upon activation, indicating that the Cd4 gene locus 
can be reactivated in redirected class II-restricted CD8+ 
cells in ThPOK-null mice [34]. This suggests differences in 
silencing mechanisms in redirected MHC class II-restricted 
CD8+ T cells that develop upon loss of ThPOK in compari-
son to wild-type MHC class I-restricted CD8+ T cells.
A crucial role for the Cd4 enhancer e4P for the initia-
tion and maintenance of CD4 expression has been shown 
by generating a conditional “floxed” e4P allele [35]. Dele-
tion of e4P was found to result in loss of CD4 expression 
in preselected DP thymocytes. However, a fraction of 
MHC class II-restricted e4P-deficient thymocytes could 
still be positively selected and, albeit at reduced levels, 
started to express CD4. This demonstrates that e4P is 
essential for the early induction of Cd4 gene expression in 
DP thymocytes and that e4P is also required for high-level 
expression of CD4 in mature thymocytes and T helper 
cells. Moreover, these data also imply the presence of an 
additional Cd4 cis-regulatory element that directs expres-
sion in mature T helper cells and this enhancer has been 
designated “maturation” enhancer [35]. However, mature 
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CD4lo e4P-deficient T cells lost CD4 expression upon acti-
vation and loss of CD4 expression was linked with cell 
proliferation after activation. This suggests that e4P is nec-
essary for the stabilization of CD4 expression upon activa-
tion. Interestingly, retroviral Cre-mediated deletion of the 
“floxed” e4P allele revealed that CD4 expression remained 
at high levels when e4P was deleted in mature T helper 
cells. The maintenance of CD4 expression correlated with 
active histone marks at the Cd4 promoter region, sug-
gesting epigenetic propagation of CD4 expression in the 
absence of e4P [35].
In contrast to e4P, deletion of e4T had no effect on 
CD4 expression in thymocytes or in peripheral mature T 
cells [35]. In addition, mice lacking both e4P and e4T had 
a similar phenotype as e4P-deficient mice, indicating that 
there is no compensatory role for e4T in the absence of e4P 
and that it is unlikely that e4T represents the “maturation” 
enhancer mentioned above. However, e4T is required for 
directing CD4 expression in a subset of lymphoid tissue 
inducer cells [35], indicating a subset-specific function for 
e4T.
Taken together, gene-targeting strategies revealed a 
crucial role for e4P in the initiation of CD4 expression 
during thymocyte development and for high-level and 
stable expression of CD4 in T helper cells, while the Cd4 
silencer is essential for the establishment of Cd4 silenc-
ing in CD8 lineage T cells. Remarkably, once mature 
T helper or cytotoxic T cells have been generated, Cd4 
expression or Cd4 silencing can be maintained indepen-
dently of e4P or S4, respectively. This suggests epige-
netic mechanisms controlling Cd4 expression in mature 
T cells.
Cis‑regulatory elements controlling the Cd8a and Cd8b1 
gene complex
The CD8 coreceptor is usually expressed as a heterodimer 
formed by the CD8α and CD8β chains on conventional T 
cells. The CD8 chains are encoded by the Cd8a and Cd8b1 
genes, which are closely linked at a distance of about 36 kb 
on mouse chromosome 6 [36] and of about 15 kb on human 
chromosome 2 [37]. However, subsets of intraepithelial 
lymphocytes (IeL) in the gut [38, 39], CD8+ dendritic cells 
[40], and a subset of human NK cells [41] express CD8αα 
homodimers. This indicates both common regulatory 
mechanisms as well as independent transcriptional control 
of Cd8a and Cd8b1 gene expression.
A complex network of cd8 enhancers direct developmental 
stage- and lineage-specific expression of the Cd8a  
and Cd8b1 genes
Similar to the analysis of the Cd4 locus, long-range DHS 
assays combined with transgenic reporter gene expression 
approaches were performed to identify cis-regulatory ele-
ments within the murine Cd8ab1 (Cd8ab) gene complex 
[42–44]. These studies resulted in the identification of at 
least five cis-regulatory elements within the Cd8ab gene 
complex that display a complex pattern of developmen-
tal stage-, subset-, and lineage-specific activities [42–47] 
(Fig. 3). The first Cd8 enhancer identified was e8I, which 
directs expression of a reporter gene in mature CD8SP thy-
mocytes, peripheral CD8+ T cells, and in CD8αα+ IeL [42, 
43]. Subsequently, four additional enhancers were iden-
tified. e8II is active in DP and CD8SP thymocytes and in 
Fig. 3  Map of the Cd8ab gene complex. The upper panel shows the 
Cd8ab gene complex and the horizontal arrows indicate the transcrip-
tional orientation of the Cd8b1 and Cd8a genes (after Gorman et al. 
[36]). Vertical black and open bars/squares indicate exons and the 3′ 
untranslated regions. Vertical arrows indicate DNase I hypersensitivity 
sites that are grouped into four clusters [42]. The red rectangles indi-
cate the location of Cd8 enhancers e8I–e8v. Only those trans-acting 
factors are indicated were binding has been confirmed in primary 
thymocytes and T cells by chromatin immunoprecipitation assays 
(see text for more details). Drawing is adapted from reference [71]. 
The following references report binding to the Cd8ab gene com-
plex: MAZR [55], Runx complexes [75], Ikaros [108], Bcl11b [107], 
SATB1 [100], ThPOK [67]
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CD8+ T cells, while e8III is an enhancer whose activity 
is restricted to DP thymocytes [46]. e8Iv is active in DP 
thymocytes and CD8+ T cells, however e8Iv also directs 
low-level expression in CD4+ T cells [46]. The activity of 
e8Iv in the transgenic setting was attributed to the obser-
vation that approximately 25 % of CD4+ T cells express 
low levels of CD8β [45], although the biological function 
of CD8β expression in a fraction of CD4+ T cells is not 
clear. Finally, enhancer e8v did not show any activity in 
transgenic reporter expression assays [45]. However if e8v 
is used together with e8I in a transgenic reporter construct, 
the combined activity of these two Cd8 enhancers directed 
expression in DP thymocytes (in addition to mature CD8SP 
and CD8+ T cells as expected from the activity of e8I 
alone), thus indicating combinatorial activity of Cd8 cis-
regulatory elements. Similar clusters of DHS have also 
been identified for the human Cd8ab gene complex and 
were shown to direct appropriate developmental expression 
in transgenic mice [48], and a cross-species comparison 
indicated several evolutionary conserved regions that over-
lap with DHS (ellmeier, unpublished results), indicating a 
similar mode of Cd8a and Cd8b1 gene regulation in man, 
mouse, rat, and dog.
The existence of Cd8 enhancers that are either specifi-
cally active in DP cells (i.e., e8III; [46]) or in mature CD8 
SP T cells (i.e., e8I; [42, 43]) provided also a potential 
molecular explanation for the transcriptional regulation 
of the Cd8 genes during CD8 lineage differentiation, i.e., 
down-regulation of CD8 in signaled DP thymocytes (loss 
of e8III activity) and “coreceptor reversal” and re-initi-
ation of CD8 expression (due to the activity of e8I) dur-
ing CD8 lineage differentiation [18]. Although the “switch 
of enhancer usage” model is very attractive to explain the 
dynamic expression of CD8, the generation of various Cd8 
enhancer-deficient mice revealed a more complex utiliza-
tion of the various cis-regulatory elements at the endoge-
nous Cd8ab gene complex during T cell development.
Gene targeting approaches to characterize Cd8 enhancer 
function
The identification of this complex regulatory mode medi-
ated by the activity of several Cd8 enhancer activities 
raised the question why so many cis-regulatory elements 
are required to direct expression of CD8. Several possibili-
ties, which are not mutually exclusive, might be imagined. 
First, as briefly discussed above, Cd8 enhancers might be 
used (in part) developmental stage-specific, thus facilitat-
ing the dynamic regulation of CD8 expression during T 
cell development. Second, some of the enhancers might be 
specific for directing Cd8a gene expression in conventional 
CD8+ T cells, while others might be specific for Cd8b1, 
a possibility that cannot be distinguished in transgenic 
reporter expression assays. Third, some of the enhancers 
displayed activity only in conventional T cells but not in 
IeLs or in DCs and therefore might regulate the T cell sub-
set-specific expression of CD8. Fourth, it is possible that 
the combined activity of all enhancers at the endogenous 
Cd8 loci is required to direct high-level expression of CD8. 
Gene targeting approaches were used to delete Cd8 enhanc-
ers to address the complexity of Cd8 enhancers in more 
detail. The first enhancer deleted was e8I [44, 46]. Despite 
its activity in mature CD8SP and CD8+ T cells in trans-
genic mice, in the absence of e8I conventional DP thymo-
cytes and peripheral CD8+ T cells express normal levels of 
CD8αβ heterodimers, with the exception of mature CD8SP 
thymocytes, which display a 20 % reduction of CD8 lev-
els [46]. This suggests that loss of e8I activity can be com-
pensated by other cis-elements in conventional T cells. 
In contrast, there is a strong reduction of CD8α expres-
sion levels on γδTCR+ as well as on αβTCR+ IeLs [44, 
46]. These data indicate that e8I is an enhancer essential 
for subset-specific expression of Cd8a in IeLs. This was 
already implied by transgenic reporter assays, since e8I is 
the only enhancer that directed expression in CD8αα+ IeLs 
[43–46].
The generation of e8II-deficient mice revealed that e8II 
is not essential for the regulation of the Cd8ab gene com-
plex [49]. There was no detectable alteration in the expres-
sion of CD8 in conventional T cells or in IeLs, suggesting 
that, like in the case of e8I, other cis-elements compensate 
for loss of e8II. Since e8I and e8II are both active in CD8+ 
T cells, e8I/e8II double-deficient mice were generated to 
test whether e8I and e8II compensate for each other upon 
deletion [49]. Surprisingly, e8I/e8II double-deficient thy-
mocytes displayed variegated expression of CD8 in DP 
thymocytes, leading to the development of a fraction of 
“CD8-negative” DP thymocytes. A similar and even more 
enhanced population of “CD8-negative” DP thymocytes 
was also observed in e8v-deficient mice [50] and later also, 
although with a much weaker phenotype, in mice lacking 
e8II/e8III [51]. The variegated expression of CD8 in e8I/
e8II, e8II/e8III and e8v-deficient thymocytes is conceptu-
ally reminiscent of position effect variegation observed 
in transgenic mice [52]. This suggested that the deletion 
of Cd8 enhancers might lead to alterations in the chroma-
tin structure of the Cd8ab gene complex and thus to an 
impaired activation of the Cd8 loci during the DN-to-DP 
transition [53]. Interestingly, those DP thymocytes that 
were able to activate the Cd8ab gene complex expressed 
normal levels of CD8, indicating that other cis-regulatory 
elements maintain CD8 expression and/or that epigenetic 
mechanisms are involved in the regulation of CD8 expres-
sion in mature CD8+ T cells. The variegated expression in 
the absence of Cd8 enhancers also implied that chromatin 
remodeling complexes might be recruited via these Cd8 
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cis-regulatory elements and that the Cd8ab gene complex 
is epigenetically regulated [53]. Indeed, the BAF (Brahma 
associated factor) chromatin remodeling complex has been 
shown to contribute to the regulation of CD8 expression. 
Mice heterozygous for Brg1, the ATPase necessary for the 
activity of the BAF complex, display variegated expression 
of CD8 in DP thymocytes [54], suggesting a potential link 
between Cd8 enhancers and the BAF complex. Moreover, 
subsequent studies in e8I/e8II-deficient mice have shown 
that CD8 variegation in DP thymocytes is accompanied 
with increased DNA methylation and reduced histone acet-
ylation in cells that failed to upregulate CD8, indicating an 
“epigenetic block” [55]. The deletion of DNA methyltrans-
ferase (Dnmt) 1 in e8I/e8II-deficient thymocytes partially 
restored the activation of the Cd8ab gene complex [55], 
highlighting the role of e8I and e8II in recruiting factors 
that lead to epigenetic alterations at the Cd8 loci.
A transcription factor network links CD4/CD8 cell‑fate 
choice and Cd4/Cd8 coreceptor gene expression
The identification of cis-regulatory elements directing the 
expression of the Cd4 and Cd8 genes provided the basis for 
experimental strategies to decipher the molecular nature of 
trans-acting factors regulating coreceptor gene expression. 
As described below, these experiments revealed that the 
Runx family of transcription factors is important for Cd4 
silencing and later studies also showed that Runx factors 
are essential for CD8 lineage differentiation. Together with 
studies that described the identification and characteriza-
tion of the transcription factor ThPOK, which is a crucial 
regulator of CD4 lineage development, important insight 
into transcriptional control mechanisms regulating core-
ceptor gene expression during T cell development as well 
as into the transcriptional network coordinating CD4/CD8 
cell-fate choice has been obtained (Fig. 4).
ThPOK: a central regulator of CD4 lineage commitment
ThPOK (also known as cKrox; encoded by the Zbtb7b 
gene, referred to here as Thpok) is a member of the 
BTB/POZ domain-containing zinc-finger transcription 
factor family [56, 57]. ThPOK was identified by Kappes 
and colleagues [58] by uncovering the molecular cause of 
the phenotype of HD (helper-deficient) mice, which lack 
mature CD4+ T cells, and independently by Bosselut and 
colleagues [59] as a factor induced in DP thymocytes upon 
MHC class II-mediated positive selection that promotes 
CD4 lineage development. HD mice acquired a sponta-
neous point mutation in Thpok, leading to an amino acid 
exchange in the third Zn-finger domain of ThPOK [60]. 
MHC class II-restricted DP cells are still positively selected 
in HD mice, however they are redirected into the CD8 lin-
eage, while MHC class I-restricted DP cells deficient for 
functional ThPOK develop normally into CD8 lineage 
cells [61]. On the other hand, transgenic overexpression of 
ThPOK on a HD-deficient background restored the devel-
opment of CD4+ T cells and in addition resulted in the redi-
rection of MHC class I-restricted DP thymocytes into the 
CD4 lineage [60]. Similar results were also obtained upon 
overexpression of ThPOK in wild-type thymocytes [59, 
60]. ThPOK is expressed in post-selection CD69+ DP thy-
mocytes and in CD4SP cells and peripheral CD4+ T cells, 
but its expression is absent in CD8 lineage T cells [59, 60]. 
It has also been shown that MHC class II-induced signals 
lead to a high induction of ThPOK expression in CD69+ 
DP thymocytes, while MHC class I-signaled DP thymo-
cytes remain ThPOK-negative, except for a small fraction 
of less than 5 % expressing only low levels of ThPOK 
[62–64]. Subsequent studies showed that ThPOK activity is 
also essential for maintaining CD4 lineage integrity in part 
by antagonizing Cd4 silencer activity [64] and by repress-
ing several CD8 lineage genes including Runx3 [63, 65]. 
In comparison, enforced expression of ThPOK in mature 
CD8+ T cells represses CD8 features leading also to the 
down-regulation of CD8 expression [66]. ThPOK has been 
shown to bind to several Cd8 enhancers in CD4SP thymo-
cytes [67]. Moreover, ThPOK interacts in vitro with class 
II histone deacetylases (HDACs) such as HDAC4/HDAC5 
and the presence of ThPOK is required to recruit class II 
Fig. 4  Transcriptional networks controlling coreceptor gene expres-
sion. Drawing showing the DN, DP, CD4SP, and CD8SP stages of 
T cell development. For each developmental step, the transcriptional 
regulators implicated in the positive and negative regulation of the 
coreceptors are indicated. For simplicity, the Cd8a and Cd8b1 genes 
are shown as a single Cd8 locus. In addition, the transcription factor 
network controlling CD4/CD8 cell-fate choice and the cross-regula-
tion between CD4 lineage promoting factors (Tox, Gata3, ThPOK; 
shown in red boxes) and CD8 lineage factors (Runx3, MAZR; shown 
in blue boxes) is described. The repressive function of Ikaros on the 
Cd4 gene is blocked by Mi-2β in DP cells (dashed line). The question 
mark indicates that it is currently not known whether MAZR affects 
CD8 lineage differentiation, in addition to the repression of Thpok, 
also by other mechanisms (see text for further details). Drawing is 
adapted from references [71, 129]
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histone deacetylases to the Cd8ab gene complex [67]. This 
might lead to the repression of the Cd8 loci during CD4 
lineage differentiation. Together, these studies clearly 
demonstrate that ThPOK is a master CD4 lineage commit-
ment factor that promotes CD4 lineage differentiation and 
represses CD8 lineage development of DP thymocytes and 
suggest that ThPOK also directly controls the Cd4 and Cd8 
gene loci.
The importance of ThPOK for the development of CD4 
lineage T cells also initiated studies to identify the cis-
regulatory elements that direct Thpok expression in MHC 
class II-signaled thymocytes. Transgenic reporter expres-
sion assays and the analysis of how Runx complexes reg-
ulate ThPOK expression revealed the existence of several 
cis-regulatory elements essential for ThPOK expression 
and gene targeting approaches confirmed the importance 
of these cis-elements in the regulation of Thpok expression 
[64, 68, 69]. The proximal Thpok enhancer (designated Pe), 
located about 3.6 kb downstream of exon 1A of the Thpok 
gene, directs expression in CD4SP and peripheral CD4+ T 
cells [68]. Interestingly, even though ThPOK expression 
was normally induced in Pe-deficient thymocytes, ThPOK 
expression was gradually lost in Pe-deficient CD4SP cells 
and CD4+ T cells, indicating that Pe is essential for the up-
modulation of ThPOK during CD4 lineage differentiation 
[64]. The other major cis-regulatory element is the Thpok 
silencer, located approximately 3 kb upstream of exon 1A 
of the Thpok gene. Deletion of the Thpok silencer results 
in derepression of ThPOK during CD8 lineage differen-
tiation and as a consequence strong reduction in CD8+ T 
cell numbers [69]. Kappes and colleagues [68] identified 
another enhancer activity that is closely associated with the 
Thpok silencer region. In a recent study, Taniuchi and col-
leagues dissected this cis-regulatory element, designated as 
thymic enhancer (Te), from the Thpok silencer activity and 
showed that it acts as a positive regulatory element essen-
tial for the induction of ThPOK expression. Interestingly, 
Gata3 was found to be associated with Te, consistent with 
its role in inducing ThPOK expression discussed below 
[70]. Transgenic reporter assays also revealed the presence 
of one additional cis-element, termed general T-lymphoid 
element (GTe) that might be involved in the transcrip-
tional maintenance of ThPOK expression [68], although its 
physiological role remains to be determined. For a detailed 
review about the transcriptional control of Thpok gene 
expression, see [57, 71].
Runx complexes: regulators of Cd4 silencing and Cd8 gene 
expression
The Runx family (Runx1, Runx2, and Runx3) of transcrip-
tion factors functions as heterodimers formed with the 
essential common cofactor CBFβ. Runx/CBFβ complexes 
play important roles in many developmental processes 
[72]. All three isoforms are known to be expressed in T 
cells [73] and the importance of Runx family proteins in 
thymocyte development and T cell lineage choice became 
clear when it was shown that Runx-binding sites within 
the Cd4 silencer region are important for silencer function 
[74] and that Runx3 is important for the development and 
proper function of CD8 lineage T cells [73]. Runx proteins 
bind the Cd4 silencer [74, 75] and are essential to silence 
CD4 expression in DN thymocytes and during CD8 line-
age development. Runx1 association with the Cd4 silencer 
is essential for repressing Cd4 in DN cells, while Runx3 is 
needed to establish epigenetic silencing of the Cd4 locus 
in CD8SP cells [73, 74]. Interestingly, CD8 lineage differ-
entiation was impaired when mutating/deleting both Runx1 
and Runx3 or CBFβ in T cells [69, 76]. At the molecular 
level, it was shown that Runx complexes bind to the Thpok 
silencer and are essential for repressing ThPOK in CD8 lin-
eage T cells. In the absence of functional Runx complexes, 
ThPOK is derepressed, leading to the development of MHC 
class I-restricted CD4 lineage T cells [69].
Runx complexes also play an important role for CD8 
expression, as they were found to be associated with Cd8 
enhancers in CD8+ T cells [75, 77]. However, Runx3-defi-
cient mice display normal CD8 expression levels in naive 
CD8+ T cells [76, 78], therefore the molecular details of 
how Runx factors regulate CD8 expression during CD8 lin-
eage development are not fully understood. As described 
in more detail below, a study from our laboratory demon-
strated that Runx complexes are essential for maintain-
ing Cd8a gene expression in activated CD8+ T cells [77], 
indicating a differential requirement of Runx3 in naive and 
activated/effector CD8+ T cells.
The observations that ThPOK represses Runx3 expres-
sion during CD4 lineage differentiation [63] while Runx 
complexes repress ThPOK during CD8 differentiation 
suggest that the interplay between Runx complexes and 
ThPOK in DP thymocytes determines CD4 vs. CD8 line-
age choice and therefore Runx3 was considered as being 
the master regulator of the CD8 lineage. However, some 
observations indicate a slightly more complex mechanism. 
while transgenic overexpression of ThPOK is sufficient to 
silence Runx3 and to abrogate the development of CD8+ 
T cells, enforced Runx3 expression does not redirect MHC 
class II-restricted thymocytes into the CD8 lineage [79], 
suggesting that other factors potentially cooperate with 
Runx3 are essential for CD8 lineage development.
MAZR: a regulator of CD8 expression in DN thymocytes 
and of CD4/CD8 cell-fate choice
One factor that might function in synergy with Runx com-
plexes during CD8 lineage development is the BTB/POZ 
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domain-containing transcription factor MAZR [56]. 
MAZR was initially identified as an interaction factor of 
the transcriptional repressor Bach2 [80]. we identified 
MAZR in a yeast one-hybrid screen as a transcriptional 
regulator that binds Cd8 enhancer e8II [55]. Subsequent 
ChIP assays revealed that MAZR is bound to several Cd8 
enhancers within the Cd8ab gene complex in DN thy-
mocytes and that retroviral-mediated enforced expres-
sion of MAZR induces variegated expression of CD8 in 
DP thymocytes [55]. This indicates that MAZR acts as a 
repressor of CD8 expression during the DN to DP transi-
tion, probably via its interaction with N-CoR corepressor 
complexes [55], which are components of larger chro-
matin remodeling complexes such as Sin3A, NURD, and 
BAF [81–83]. MAZR expression is downregulated in DP 
cells and less MAZR is recruited to the Cd8 loci com-
pared to DN thymocytes [55]. In parallel, positive-acting 
factors and complexes might be induced during the DN to 
DP transition and recruited to the Cd8 gene loci leading 
to a transcriptional “on” state facilitating CD8 expression. 
It is tempting to hypothesize that the change in the rela-
tive abundance of negative and positive-acting factors and 
chromatin-modifying complexes at the Cd8 gene complex 
during the DN to DP transition determines the initiation of 
Cd8a and Cd8b1 gene expression. In the absence of e8I/
e8II, positive-acting factors are less efficiently recruited to 
the Cd8ab gene complex. Therefore negative factors are 
more abundant and CD8 expression is impaired in DP thy-
mocytes. If MAZR expression is enforced, negative-acting 
factors are more abundantly recruited and hence CD8 
expression is variegated. This model is supported by the 
observation that the deletion of MAZR in e8I/e8II-defi-
cient thymocytes restores CD8 expression [84], similar to 
what is observed upon deletion of DNA methyltransferase 
1 (Dnmt1) on an e8I/e8II-deficient background, since the 
relative balance between negative- and positive-acting fac-
tors might be again shifted towards a transcriptional “on” 
state.
Moreover, the analysis of MAZR-deficient mice 
revealed that MAZR is part of the transcription factor 
network controlling CD4/CD8 cell-fate choice. MAZR 
is bound to the Thpok silencer and essential to repress 
ThPOK in MHC class I-signaled thymocytes [84]. In the 
absence of MAZR, a fraction of MHC class I-signaled DP 
cells derepresses ThPOK, resulting in redirection into CD4 
lineage T cells. In addition, MAZR was found to interact 
with Runx complexes, which might indicate synergistic 
repression of ThPOK [84] and potentially also synergistic 
activities in mediating CD8 lineage differentiation. Finally, 
MAZR-deficient mice are smaller in size and are born at 
reduced Mendelian frequencies due to impaired embry-
onic development [84, 85]. Moreover, MAZR has been 
implicated to function as a tumor suppressor gene [86] and 
MAZR-null male mice are infertile [84, 87]. Thus, MAZR 
also has important roles in other cell lineages beyond the 
hematopoietic system.
Ikaros, Mi-2β, and AP4: additional factors regulating Cd4 
silencer activity
Mi-2β, an ATP-dependent chromatin remodeling fac-
tor [88] and Ikaros, a transcriptional regulator with many 
functions during lymphocyte development that also asso-
ciates with Mi-2β [89] and other chromatin remodeling 
complexes [90, 91], were shown to regulate CD4 expres-
sion during early stages of thymocyte development. Loss 
of Ikaros leads to Cd4 derepression in DN thymocytes [89], 
while Mi-2β deficiency leads to the emergence of DP cells 
that display strongly reduced CD4 expression levels [89]. 
Interestingly, mice lacking both factors displayed a reversal 
of both phenotypes, thus revealing an antagonistic interplay 
between Mi-2β and Ikaros in controlling Cd4 gene expres-
sion during the DN to DP transition. while the association 
of Ikaros with the Cd4 silencer mediates Cd4 repression in 
DN cells, the simultaneous binding of Ikaros and Mi-2β 
in DP thymocytes leads to the inactivation of Cd4 silencer 
activity, in part by Mi-2β-mediated recruitment of histone 
acetyltransferases [89].
One additional transcription factor involved in the 
regulation of Cd4 silencing is the basic helix-loop-helix 
(bHLH) ZIP protein AP4, which was found to be neces-
sary for efficient Cd4 repression both in DN thymocytes as 
well as in memory CD8+ T cells [92]. AP4 binds to e4P but 
not to the Cd4 promoter or Cd4 silencer and interacts with 
Runx1 in cells that have silenced CD4 expression. AP4-
deficient mice show Cd4 derepression in DN cells. Moreo-
ver, CD4 expression is modulated in AP4-deficient memory 
CD8+ T cells that contain a mutated Cd4 silencer allele, 
indicated by an increase in the numbers of CD8 effector T 
cells that express CD4 in comparison to cells carrying the 
mutant Cd4 silencer only [92]. Thus, AP4 is another factor 
that contributes to Cd4 silencing both in DN thymocytes 
and in CD8+ T cells.
The bHLH factors HeB and e2A control the activity  
of the Cd4 enhancer e4P
Soon after the discovery of the Cd4 enhancer e4P, experi-
ments were initiated to identify transcription factors that 
interact with this cis-regulatory element. The bHLH pro-
teins HeB and e2A were found to bind to e4P [93] and 
gene-targeting experiments revealed that HeB is essential 
for the up-regulation of CD4 expression in DP thymocytes, 
since loss of HeB leads to the generation of increased 
CD4loCD8+ and reduced CD4+CD8+ DP thymocyte sub-
sets [94]. Interestingly, HeB-deficient mice display normal 
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CD4 expression in peripheral T cells, although T helper 
cell numbers were reduced in comparison to wild-type 
mice [94]. This is in part reminiscent of the phenotype 
observed in e4P-deficient mice [35]. In addition, mice with 
a combined heterozygosity for HeB and e2A displayed a 
similarly reduced expression of CD4, indicating that CD4 
expression is sensitive to the expression levels of the bHLH 
factors HeB and e2A [94, 95]. The combined deletion of 
HeB and e2A in T cells (using Cd4-Cre) revealed that 
both proteins are required to maintain thymocytes at the DP 
stage until a functional T cell receptor is expressed, since 
HeB/e2A-null DP cells can progress to the SP stage even 
without a TCR signal [96]. However, the majority of SP 
cells in the absence of HeB/e2A were CD8+ cells, indi-
cating that HeB and e2A are essential for CD4 lineage 
development [96]. Consistently, deletion of the e-protein 
inhibitors Id2 and Id3 allowed CD4 lineage development 
but blocked the generation of CD8 lineage T cells [97]. 
Furthermore, the analysis of ThPOK and Gata3 expression 
in HeB/e2A-null DP thymocytes suggest that HeB/e2A 
function upstream of CD4 lineage specification [97].
SATB1, Bcl11b, and Ikaros: transcription factors 
implicated in the regulation of Cd8 gene expression
SATB1 (special AT-rich binding protein) is a matrix 
attachment region (MAR) binding protein that can recruit 
chromatin remodeling complexes to SATB1 target sites 
[98, 99]. At the Cd8ab gene complex, SATB1 binds to a 
MAR designated L2a within Cd8 enhancer e8v in DP and 
CD8SP thymocytes [100]. SATB1-deficient mice display a 
severe block at the DP stage of T cell development [101]. 
Mice with a knockdown mutation of SATB1 (via T cell-
specific expression of antisense Satb1) display reduced 
percentages of CD8SP thymocytes and T cells, although 
CD8 expression levels were not altered in SATB1 antisense 
thymocytes [102]. However, a closer in vitro analysis of 
SATB1-deficient as well as SATB1-antisense DP thymo-
cytes revealed that SATB1 binds to e8III and that SATB1 is 
essential to re-express CD8 in signaled (PMA/ionomycin) 
DP thymocytes in response to IL-7 [103]. This suggests an 
important positive role for SATB1 in the regulation of CD8 
expression during CD8 lineage development, although the 
molecular details of how SATB1 mediates the activation of 
the Cd8 loci are not yet known.
The zinc-finger transcription factor Bcl11b plays mul-
tiple roles during T cell development. Germline deletion 
of Bcl11b initially demonstrated a crucial role for this 
factor in Tcrb recombination and β-selection, resulting in 
a block at the DN stage in the absence of Bcl11b [104]. 
Conditional deletion of Bcl11b using either Cd4-Cre or 
Lck-Cre revealed additional roles for Bcl11b for the sur-
vival of DP thymocytes as well as positive selection, since 
conditional Bcl11b knockout mice showed a developmen-
tal block at the DP stage [105, 106]. Bcl11b-deficient DP 
(CD4+CD8+CD3lo) cells displayed altered expression of 
more than 1,000 genes, and Thpok as well as Runx3 were 
found to be up-regulated in the absence of Bcl11b. Moreo-
ver, ChIP-seq approaches revealed that Bcl11b binds to 
several regions within the Thpok and Runx3 gene loci, sug-
gesting direct repression of ThPOK and Runx3 by Bcl11b 
in DP thymocytes [106]. The role of Bcl11b in controlling 
CD8 expression only became clear when it was condition-
ally ablated in mature CD8+ T cells (using distal Lck-Cre). 
Bcl11b is associated with the Cd8 enhancers e8I, e8Iv, and 
e8v and Bcl11b is necessary to maintain CD8 expression 
in mature CD8+ T cells during bacterial infection as well as 
during in vitro activation [107].
Beside its role in the regulation of Cd4 gene expres-
sion (as discussed above), Ikaros has also been implicated 
in the control of the Cd8ab gene complex. Kioussis and 
colleagues [108] showed that Ikaros is associated in vivo 
with Cd8 enhancers e8I and e8v. Ikaros appears to have a 
positive regulatory activity for the Cd8 loci, since reduced 
levels of Ikaros (in Ikzf+/− mice) lead to an increase in the 
variegated expression of a reporter gene driven by Cd8 
enhancers. In addition, mice heterozygous for Ikaros and 
deficient for the Ikaros family member Aiolos showed 
impaired activation of the Cd8ab gene complex resulting in 
the development of “CD8-negative” DP thymocytes [108], 
similar to the phenotype observed in e8I/e8II- [49] e8II/
e8III- [51], and e8v-deficient [50] thymocytes or in BAF 
complex mutant mice [54].
Other transcription factors involved in CD4/CD8 cell-fate 
choice
Additional transcription factors implicated in the regula-
tion of CD4/CD8 lineage differentiation are Tox, Gata3 
and c-Myb. Overexpression of Tox, a member of the high-
mobility group box protein family, leads to an enlarged 
CD8SP thymocyte pool at the expense of CD4SP cells, 
which might be due to enhanced Runx3 expression in 
Tox transgenic mice [109]. In Tox-deficient mice, thymo-
cyte development is partially blocked at the CD4loCD8lo 
stage and CD4SP generation is completely abolished, 
whereas some CD8SP cells still develop [110]. Interest-
ingly, ThPOK is not expressed in CD4loCD8lo thymocytes 
of Tox-deficient TCR transgenic mice, indicating that Tox 
might carry out its role in CD4 lineage differentiation 
upstream of ThPOK [110]. The zinc finger protein Gata3 
is another transcription factor shown to be important for the 
generation of CD4+ T cells during thymocyte differentia-
tion. In conditional Gata3 knockout mice, the numbers of 
CD4SP cells were strongly reduced, whereas CD8SP cells 
were unperturbed [111]. A subsequent study found that 
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this might be partially explained by the observation that 
Gata3 binds the Thpok locus at a regulatory site necessary 
for its expression and that the induction of ThPOK expres-
sion depends on Gata3 [62]. However, enforcing ThPOK 
expression cannot compensate for loss of Gata3 [62]. 
Moreover, Gata3 represses Runx3 expression and binds 
the Runx3 locus in vivo [112]. This indicates that Gata3 is 
not only important for the induction of CD4 lineage genes 
but also for the repression of CD8 lineage genes. Another 
transcription factor implicated in CD4/CD8 lineage choice 
is c-Myb, which has been shown to have multiple func-
tions during thymocyte development. c-Myb is essential for 
developmental progression through the DN3 stages, for the 
survival of preselection DP cells and for the differentiation 
of CD4SP thymocytes [113]. The phenotype of conditional 
c-Myb-deficient thymocytes resembles in part the pheno-
type of Gata3-deficient thymocytes, i.e., impaired CD4 lin-
eage development and unperturbed CD8 lineage develop-
ment [113, 114]. This was attributed to the ability of c-Myb 
to bind and to regulate the Gata3 locus, since c-Myb-
deficient thymocytes display reduced expression of Gata3 
[114]. This suggests that c-Myb acts upstream of Gata3 and 
potentially also upstream of other CD4 lineage specifica-
tion and commitment factors. However, there is no indica-
tion that Tox, GATA3, or c-Myb are directly involved in the 
regulation of Cd4, Cd8a, and Cd8b1 gene expression.
Differential regulation of coreceptor gene expression 
between naive and effector/memory T cells
The discovery of the cis-regulatory networks directing Cd4 
and Cd8 coreceptor gene expression provided important 
insights into transcriptional control mechanisms in T cells. 
The identification of enhancers that direct expression only 
either in immature DP cells or in mature T cells indicated 
that different cis-elements are required at distinct develop-
mental stages. However, subsequent studies demonstrated 
a differential requirement for enhancers also within mature 
T cell subsets. The first experimental evidence came from 
studies that showed that e4P is not sufficient to maintain 
transgene expression after activation of mature CD4+ T 
cells [115], whereas the expression of the endogenous Cd4 
gene is maintained upon activation. This suggests that the 
expression of CD4 is differentially regulated between naive 
and effector/memory CD4+ T cells. Moreover, this finding 
implies the existence of an additional Cd4 enhancer specifi-
cally required for effector/memory CD4+ T cells, however 
the molecular identity of this cis-element remains to be 
determined.
Our laboratory revealed that a transcriptional program 
that is distinct from naive T cells regulates Cd8a gene 
expression during CD8+ effector T cell differentiation 
and that Cd8 enhancer e8I and Runx/CBFβ complexes are 
required for CD8 expression in activated CD8+ T cells [77]. 
This finding was initiated by the observation that subsets of 
CD8αβ+ T cells transiently express CD8αα homodimers in 
an e8I-dependent manner upon activation [116]. Cheroutre 
and colleagues [116] linked CD8α expression on CD8αβ+ 
T cells to the survival and differentiation of memory pre-
cursor cells into memory cells and reported impaired mem-
ory formation in e8I-deficient mice. However, it was also 
shown that memory responses can occur in the absence of 
CD8α expression in e8I-deficient mice [117, 118]. Inter-
estingly, in one of the studies Kaech and colleagues [117] 
observed a decrease in CD8αβ expression levels on splenic 
T cells in LCMv-infected e8I-deficient mice. This pro-
vided the first indication that e8I-deficient activated CD8+ 
T cells have a defect in CD8 expression upon activation. 
Subsequent studies revealed mechanistic insight into how 
CD8 expression is regulated in naive versus activated 
effector T cells. e8I-deficient mice down-regulated CD8α 
upon activation and this correlated with enhanced repres-
sive histone marks at the Cd8a promoter in the absence of 
e8I, while Cd8b1 expression levels and histone marks at 
the Cd8b1 promoter region remained unaffected [77]. The 
treatment of e8I-deficient CD8+ T cells with the HDAC 
inhibitor trichostatin A blocked the down-regulation of 
CD8α expression, suggesting epigenetic control of the 
Cd8a gene locus in activated CD8+ T cells [77]. Moreo-
ver, Runx/CBFβ complexes bound the Cd8ab gene cluster 
in activated CD8+ T cells, and Cd8a gene expression was 
down-regulated in Runx3- or CBFβ-deficient CD8+ T cells 
as observed in e8I-deficient T cells. This strongly suggests 
direct control of the Cd8a locus by Runx complexes dur-
ing CD8+ T cell activation. Remarkably, CD8+ effector T 
cells maintained high levels of CD8α when CBFβ was con-
ditionally deleted after CD8+ T cells were activated [77]. 
Thus, naive and effector CD8+ T cells utilize different cis-
regulatory elements and mechanisms to regulate Cd8a gene 
expression. while multiple cis-elements that in part might 
have redundant functions drive CD8 expression in naive T 
cells, there is e8I- and Runx3/CBFβ-dependent epigenetic 
programming of the Cd8a locus during CD8+ T cell acti-
vation. The observation that Cd8a expression can be main-
tained in the absence of e8I/Runx complexes is reminis-
cent to the above described study demonstrating that CD4 
expression remained at high levels when e4P was deleted 
in mature T helper cells [35]. Together, these data indi-
cate epigenetic regulation of coreceptor gene expression in 
mature T cells.
Interestingly, a recent study suggests a crucial role for 
the Cd8 enhancer e8I in directing Cd8a gene expression in 
a distinct CD4+CD8αα+ effector T cell subset with CTL 
features that is localized in the gut [119]. It has been shown 
that some conventional CD4+ T cells, despite their initial 
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commitment to the CD4+ helper fate and the expression 
of MHC class II-restricted αβTCRs, can get functionally 
reprogrammed and acquire CTL features [119, 120]. This 
reprogramming is induced in some CD4+ T cells due to 
activation-induced loss of ThPOK expression, which also 
leads to a Cd8 enhancer e8I-dependent induction of Cd8a 
but not of Cd8b1 gene expression and thus the generation 
of CD4+CD8αα+ effector T cells [119]. Interestingly, it 
has also been shown that TGFβ can induce CD8α expres-
sion on conventional CD4+ T cells [121]. Notably, e8I-
deficient mice displayed reduced CD8αα on IeLs [44, 46] 
and a much lower percentage of CD4+CD8αα+ IeLs [119]. 
Together, these findings support the idea that e8I is a cru-
cial enhancer required in peripheral T cells for the modula-
tion of Cd8a gene expression.
Regulation of the spatial organization of the Cd4  
and Cd8 loci
In addition to the above-described interactions between cis-
regulatory elements and transcription factors, the spatial 
organization of chromosomes and gene loci and the com-
munication between cis-regulatory elements is also impor-
tant for the proper transcriptional regulation of coreceptor 
gene expression during CD4/CD8 lineage differentiation. 
Merkenschlager and colleagues [122] as well as Robey and 
colleagues [123] showed that in MHC class II-selected DP 
thymocytes that become CD4SP cells the Cd8 gene loci are 
relocated to centromeric heterochromatin areas where gene 
transcription is stably silenced. In contrast, in DP cells that 
are positively selected on MHC class I to develop into CD8 
lineage cells, the Cd4 gene was found to be associated with 
heterochromatin at this stage. Thus, the repositioning of 
Cd4 and Cd8 coreceptor alleles within the nucleus is pre-
dictive for CD4/CD8 lineage choice [122, 123].
The nuclear position of the Cd8 loci relative to its chro-
mosomal territory (CT) during T cell development has 
been analyzed in more detail by Kioussis and colleagues 
[124]. Using three-dimensional fluorescent in situ hybridi-
zation (3D FISH) technology, the authors showed that the 
Cd8 genes are in close proximity to the center of their CT 
in CD8 non-expressing cells (DN, CD4SP), while the Cd8 
genes are relocated outside their CT centers in cells that 
actively express CD8 (DP, CD8SP). Moreover, by per-
forming chromosome conformation capture (3C) assays, a 
frequent physical contact between Cd8 enhancers and the 
Cd8a promoter was detected in CD8 expressing cells. In 
contrast, in CD8 non-expressing cells this interaction was 
significantly decreased [124]. These observations suggest 
that the movement of the Cd8 loci outside its CT leads to a 
spatial clustering of cis-regulatory elements and the forma-
tion of a chromatin hub that facilitates Cd8 gene expression.
An example of gene regulation via chromatin looping 
that facilitates the interaction between cis-regulatory ele-
ments is the regulation of the Cd4 gene locus during the 
progression from the DN to the DP stage. Runx1 promotes 
the interaction between the Cd4 silencer and the proximal 
Cd4 enhancer e4P in DN cells [125]. Upon differentiation 
to the DP stage Runx1 expression decreases allowing the 
elongation factor P-TeFb to interact with RNAPII, which 
leads to the formation of a productive chromatin loop that 
enables Cd4 gene expression.
A study published by Skok and colleagues [126] pro-
vided new mechanistic insight into the long-range control 
of Cd4 and Cd8 expression by distant enhancers, silencer, 
and promoters. Using 3D FISH combined with confocal 
laser scanning microscopy, the authors showed that the 
interchromosomal association of the Cd4 and Cd8 gene 
loci is a crucial mechanism that controls the regulated 
expression of coreceptors during T cell development. when 
measuring the distance between Cd4/Cd8 loci in murine 
thymocytes at different developmental stages (DN, DP, 
CD4+CD8lo, CD4SP and CD8SP), the strongest physical 
interaction between the Cd4/Cd8 loci was observed in cells 
that expressed CD8 (DP and CD8SP). Thus, the close asso-
ciation of the Cd4 and Cd8 loci correlates with activated 
Cd8 gene transcription in DP and CD8SP cells. This sug-
gested that genomic elements regulating Cd8 gene tran-
scription might be involved in influencing the Cd4/Cd8 loci 
association. To test this hypothesis, the association of Cd4/
Cd8 loci in Cd8 enhancer e8I/e8II-deficient DP thymo-
cytes was assessed. As described above, a fraction of e8I/
e8II DP thymocytes did not express CD8 (and hence were 
referred as “CD8-negative” DP cells) due to impaired up-
regulation of CD8 during the DN to DP transition [55]. In 
“CD8-negative” e8I/e8II DP thymocytes, there was a sig-
nificantly reduced Cd4-Cd8 interaction accompanied by a 
strong reduction in Cd8 gene transcription in comparison 
to CD8 expressing e8I/e8II-deficient DP thymocytes [126]. 
Consistently, Cd8 loci association with pericentromeric 
heterochromatin was observed at an increased percentage 
in “CD8-negative” e8I/e8II-null DP cells correlating with 
an epigenetic “off” state of the Cd8 locus. In summary, 
these findings suggest a crucial role for e8I/e8II in regu-
lating Cd4/Cd8 loci association. These studies also sug-
gest that during thymocyte development CD4/CD8 cell-
fate choice might be in part implemented by the physical 
interaction between the Cd4 and Cd8 genes mediated by 
cis-regulatory sequences. However, the exact mechanism 
of how cis-regulatory elements and gene loci find each 
other in chromatin hubs remains elusive. It is conceivable 
that trans-acting proteins are involved in this process, since 
they provide binding specificity and also mediate protein–
protein interactions. ThPOK and Runx proteins are prom-
ising candidate factors for the regulation of Cd4/Cd8 loci 
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association, since they control CD4/CD8 cell-fate choice 
and the mutual exclusive expression of CD4 and CD8 core-
ceptor molecules in mature T cells. Indeed, Runx3 medi-
ates the association of the Cd4 and Cd8 loci by binding to 
the Cd4 silencer and predominantly to e8I, whereas the 
binding of ThPOK to the Cd4 silencer reverses the asso-
ciation of both loci [126]. while the close association 
between the Cd4 and Cd8 gene loci favors the expression 
of the CD8 coreceptor molecule in DP and CD8SP, the dis-
ruption of this interaction by ThPOK leads to the termina-
tion of Cd8 expression during CD4 lineage development. 
This raises the exciting hypothesis that ThPOK and Runx3, 
essential factors for CD4/CD8 cell-fate choice, also control 
the association of the Cd4 and Cd8 gene loci. Collectively, 
these studies suggest that the generation of chromatin loops 
mediated by antagonizing transcription factors might con-
trol the expression of coregulated genes.
Conclusions
Research performed during the last two decades revealed 
comprehensive mechanistic insight into the developmental 
stage- and subset/lineage-specific regulation of CD4 and 
CD8 coreceptor expression and also into the interchromo-
somal crosstalk between the Cd4 and Cd8 gene loci. These 
studies thus provided important insight into transcriptional 
control mechanisms during T cell development and in 
peripheral effector T cells in general. Moreover, the iden-
tification of transcription factors involved in the transcrip-
tional regulation of CD4 and CD8 significantly advanced 
the knowledge about the transcription factor network regu-
lating CD4/CD8 cell-fate choice of DP thymocytes.
Although the Cd4 and Cd8 gene loci represent probably 
one of the best-characterized gene loci in T cells, several 
important questions remain to be addressed. which cis-
regulatory element at the Cd4 locus represents the “matura-
tion” enhancer and how is CD4 expression maintained in 
CD4+ effector T cells? How is Cd8 gene expression (epi-
genetically?) maintained in naive CD8+ T cells in the com-
bined absence of e8I and e8II? Moreover, the cis-elements 
required to direct expression of CD4 or CD8α in DCs have 
not been identified. It is also not known whether a unique 
negative-acting cis-regulatory element (Cd8 “silencer”) or 
repressive transcription factors (targeting potentially sev-
eral cis-elements) are required to shut off CD8 expression 
during CD4 T cell lineage differentiation. Finally, future 
studies using ChIP-seq approaches are also essential in 
understanding how the recruitment of transcription factors 
to the Cd4 and Cd8 gene loci at different developmental 
stages and in effector T cells is regulated. This could reveal 
whether there is a hierarchy in the recruitment of transcrip-
tion factors and chromatin remodeling complexes and how 
the recruitment of these factors is linked to epigenetic reg-
ulation of coreceptor expression. It can be expected that 
answers to these questions will provide novel insight into 
transcriptional control mechanisms in T cells and will also 
lead to a better understanding of how CD4/CD8 lineage 
differentiation is regulated during T cell development.
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